A randomised controlled trial of fluoxetine versus naltrexone in compulsive sexual behaviour disorder: presentation of the study protocol
Background Compulsive sexual behaviour disorder is a new disorder in the International Classification of Diseases (ICD-11), and is associated with negative consequences in different areas of life. Evidence for pharmacological treatment of compulsive sexual behaviour disorder is weak and treatment op...
Saved in:
Main Authors: | Jussi Jokinen, Josephine Savard, Katarina Görts Öberg, Cecilia Dhejne |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2022-06-01
|
Series: | BMJ Open |
Online Access: | https://bmjopen.bmj.com/content/12/6/e051756.full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Sexual Functions in Obsessive Compulsive Disorder Patients: A Case Report
by: Nergis LAPSEKÝLÝ, et al.
Published: (2012-12-01) -
Sexual Functions in Obsessive Compulsive Disorder Patients: A Case Report
by: Nergis LAPSEKİLİ, et al.
Published: (2012-11-01) -
Antiviral efficacy of fluoxetine in early symptomatic COVID-19: an open-label, randomised, controlled, adaptive platform trial (PLATCOV)Research in context
by: Podjanee Jittamala, et al.
Published: (2025-02-01) -
Teratogenic Effects of Coadministration of Fluoxetine and Olanzapine on Rat Fetuses
by: Azam Bakhtiarian, et al.
Published: (2014-01-01) -
Trial protocol of an open-label pilot study of oral naltrexone–bupropion combination pharmacotherapy for the treatment of methamphetamine use disorder (the NABU trial)
by: Jonathan Brett, et al.
Published: (2025-02-01)